← Calendar

Ticker

AXSM

Axsome Therapeutics, Inc.

7 catalysts on file

AXSM

Axsome Therapeutics, Inc.

PDUFA Confirmed

AXS-05

Alzheimer’s disease agitation

113d ago Apr 30, 2026

SEC 8-K verified 2mo ago

Countdown card →

AXSM

Axsome Therapeutics, Inc.

Approval Confirmed

Auvelity

agitation associated with dementia due to Alzheimer’s disease

113d ago Apr 30, 2026

SEC 8-K verified 2mo ago

Countdown card →

AXSM

Axsome Therapeutics, Inc.

Phase 1 AI-extracted

AXS-05

smoking cessation

52d ago ~ Jun 30, 2026

SEC 8-K verified 2mo ago

Countdown card →

AXSM

Axsome Therapeutics, Inc.

Phase 2 AI-extracted

solriamfetol

attention deficit hyperactivity disorder (ADHD)

52d ago ~ Jun 30, 2026

SEC 8-K verified 2mo ago

Countdown card →

AXSM

Axsome Therapeutics, Inc.

PDUFA AI-extracted

AXS-12

cataplexy in narcolepsy

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →

AXSM

Axsome Therapeutics, Inc.

Phase 3 Confirmed

solriamfetol

major depressive disorder (MDD) with EDS symptoms

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →

AXSM

Axsome Therapeutics, Inc.

PDUFA Confirmed

AUVELITY

agitation associated with dementia due to Alzheimer’s disease

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →